Nuo Therapeutics, Inc. (AURX) › Gross ProfitNuo Therapeutics, Inc. (AURX) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2010: $2.30M2011: $4.52M2012: $6.65M2013: $3.12M2014: $991.2K2015: $3.54M2017: -$370.0K2018: $1.21M2019: $31.6K2020: $02021: $02022: $93.0K2023: $482.4K2024: $1.06M2025: $2.22M$2.22M2010Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$2.22M+108.8%2024$1.06M+120.2%2023$482.4K+418.5%2022$93.0K—2021$0—2020$0-100.0%2019$31.6K-97.4%2018$1.21M+426.4%2017-$370.0K—2015$3.54M+257.5%2014$991.2K-68.2%2013$3.12M-53.1%2012$6.65M+47.1%2011$4.52M+96.7%2010$2.30M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share